Zimmer Biomet Holdings, Inc. (ZBH:NYSE) closed at $98.56 on October 23, 2026, down 0.25% on the day. The stock trades 5.4% below its 52-week high of $104.15 and 24.6% above its 52-week low of $79.12. Over the past year, it lost 4.3%. Zimmer Biomet Holdings, Inc. is part of the Health Care sector (Industrial Specialties).
In 252 trading sessions since October 23, 2025, ZBH closed higher on 128 days (51%). Its best day was May 12, 2026 (+4.76%) and its worst was November 5, 2025 (-15.15%). The stock moved 10% or more in a single session 2 times.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental. The company provides orthopedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and spinal fusion stimulators. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic...
Find more stocks like ZBH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.